| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 10/08/2009 | US20090253632 Therapeutic peptides and method |
| 10/08/2009 | US20090253631 Anti-Inflammatory Peptides |
| 10/08/2009 | US20090253629 Use of defensins against meningitis |
| 10/08/2009 | US20090253624 Pharmacologically active antiviral peptides and methods of use |
| 10/08/2009 | US20090253619 Novel peptide involved in energy homeostasis |
| 10/08/2009 | US20090253206 Nuclear transport agent and method for producing said agent |
| 10/08/2009 | US20090252752 Kdr peptides and vaccines comprising the same |
| 10/08/2009 | US20090252728 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 10/08/2009 | DE102005031755B4 Salmonella spp. Salmonella spp. bindende Peptide, dafür kodierende Nukleinsäuren deren Verwenduen und Verfahren und Kits zur Anreicherung, Immobilisierungen und zum Nachweis von Salmonella spp. binding peptides, nucleic acids encoding the Verwenduen and methods and kits for enrichment, immobilization and detection of Salmonella spp. |
| 10/08/2009 | CA2720277A1 Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same |
| 10/08/2009 | CA2720173A1 Highly bridged peptides from actinomadura namibiensis |
| 10/08/2009 | CA2719964A1 Partial peptide of survivin presented on mhc class ii molecule and use thereof |
| 10/08/2009 | CA2718148A1 Oxytocin analogues |
| 10/07/2009 | EP2107374A1 Polypeptide for diagnosis of vaccination |
| 10/07/2009 | EP2107110A2 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 10/07/2009 | EP2106802A1 Modified peptides as synthetic vaccines in amyloid-associated disease |
| 10/07/2009 | EP2106446A1 Stabilization of cyclic peptide structures |
| 10/07/2009 | EP2106404A2 Compositions and methods for inducing angiogenesis |
| 10/07/2009 | EP2032596B1 Neuroprotective compounds and uses thereof |
| 10/07/2009 | EP1584627B1 Dimerized peptide |
| 10/07/2009 | EP1434791B1 Specific binding agents of human angiopoietin-2 |
| 10/07/2009 | CN101553500A GnRH peptide derivative (gonadotropin-releasing hormone) |
| 10/07/2009 | CN101550181A Human papilloma virus 16 type E7 protein functional antagonist peptide and encoding gene and application thereof |
| 10/07/2009 | CN101549148A Application of polypeptide in preparing the medicine promoting the transformation from endocardium cell to interstitial cell |
| 10/07/2009 | CN100547000C Hornet anti-bacterial peptide, its preparing method and use |
| 10/06/2009 | US7598344 bi-functionally-linked biopolymer, wherein the functional linkage is between a biomaterial surface and cells or biologic molecules; takes advantage of molecular screening methods to prepare molecular structures with specific binding motifs and/or b |
| 10/06/2009 | US7598343 have a maximum impurity level of Asp9-bivalirudin that does not exceed about 0.6%; anticoagulant ; batches have a pH adjusted by a base sodium hydroxide about 5-6; Hirulog-8; thrombin peptide inhibitor |
| 10/06/2009 | US7598341 Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs |
| 10/06/2009 | US7598050 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein |
| 10/06/2009 | US7597904 casein-derived peptides obtained by hydrolysis of casein by a food grade bacteria containing Lactobacillus helveticusto provide a fermented dairy product containing metalloproteinases inhibitory agent |
| 10/06/2009 | US7597894 Antigen presenting cells and dendritic cells; inducing immunology response |
| 10/06/2009 | US7597875 Diaminedioxime radiometal complexes |
| 10/06/2009 | CA2381348C Lck-derived peptides activating ctls |
| 10/01/2009 | WO2009119662A1 Peptide capable of inducing autophagic cell death |
| 10/01/2009 | WO2009119455A1 Cancer cell motility and cancer cell infiltration inhibitor |
| 10/01/2009 | US20090247608 Targeting Lipids |
| 10/01/2009 | US20090247467 Peptide epitopes of vegfr-2/kdr that inhibit angiogenesis |
| 10/01/2009 | US20090247464 Compositions and Methods for Topical Application and Transdermal Delivery of an Oligopeptide |
| 10/01/2009 | US20090247463 Polymer-based sustained release device |
| 10/01/2009 | US20090247455 Isolation of Inhibitors of IRES-Mediated Translation |
| 10/01/2009 | US20090246340 Synthetic Ligands Able to Bind Ochratoxin A and Uses Thereof |
| 10/01/2009 | US20090246217 Novel Peptides for Treating and Preventing Immune-Related Disorders, Including Treating and Preventing Infection by Modulating Innate Immunity |
| 10/01/2009 | US20090246133 Methods and compositions related to internalizing rgd peptides |
| 09/30/2009 | EP2105501A1 Novel immunotherapy against neuronal and brain tumors |
| 09/30/2009 | EP2105141A1 Short bioactive peptides and methods for their use |
| 09/30/2009 | CN101544688A Cyclo-pentapeptide apoptosis enzyme inhibitor and method for preparing same |
| 09/29/2009 | US7595299 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 09/29/2009 | US7595298 Ala-Arg-Nal-Cys-Tyr-Arg-Lys-DLys-Pro-Tyr-Arg-Cit-Cys-Arg; viricide; low cytotoxicity |
| 09/29/2009 | US7595297 Method of reducing injury to mammalian cells |
| 09/29/2009 | US7595053 synthetic polypeptide biodrugs for treating viral disease; envelope protein, antigens, consisting of amino acid sequances from virus, more potent, protecting from T helper and B cell immunity |
| 09/29/2009 | US7595052 Composition and method for the prevention and/or the treatment of allergy |
| 09/29/2009 | CA2334730C Novel cyclosporins |
| 09/29/2009 | CA2322052C Calcium salts of lipopeptide antibiotics, method for producing same and their use |
| 09/29/2009 | CA2319701C Method of promoting erythropoiesis |
| 09/29/2009 | CA1341598C Acid-labile sub-unit (als) of insulin-like growth factor binding proteincomplex |
| 09/24/2009 | WO2009117480A2 Histidine related compounds for identifying and blocking amyloid beta ion channels |
| 09/24/2009 | WO2009091586A3 Peptides and methods of use as therapeutics and screening agents |
| 09/24/2009 | WO2009079053A3 High affinity metal-oxide binding peptides with reversible binding |
| 09/24/2009 | WO2009055005A9 Competitive inhibitors of invariant chain expression and/or ectopic clip binding |
| 09/24/2009 | WO2009044279A3 Peptides having antimicrobial and/or biosurfactant properties |
| 09/24/2009 | WO2008057608A3 Synthetic peptide amides |
| 09/24/2009 | US20090240030 Biomolecular coupling methods using 1,3-dipolar cycloaddition chemistry |
| 09/24/2009 | US20090240029 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides |
| 09/24/2009 | US20090239806 Glypican-3 (gpc3)-derived tumor rejection antigenic peptides useful for hla-a2-positive patients and pharmaceutical comprising the same |
| 09/24/2009 | US20090239792 Short fatty acid tail polymyxin derivatives and uses thereof |
| 09/24/2009 | US20090239755 Identification of Compounds Modifying A Cellular Response |
| 09/24/2009 | US20090239246 Biomarkers |
| 09/24/2009 | US20090238886 Retro-Inversion Peptides That Target GIT Transport Receptors and Related Methods |
| 09/24/2009 | US20090238817 Anti-cell proliferative compounds and methods of use |
| 09/23/2009 | EP2103630A1 Preparation of low bleeding anticoagulant fusion protein and its use |
| 09/23/2009 | EP2103624A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 09/23/2009 | EP2101802A2 Inhibiting collagen-induced platelet aggregation and activation with peptide variants |
| 09/23/2009 | EP1581557B1 Metastin derivatives and their use |
| 09/23/2009 | CN101538319A Polypeptide for detecting polytype human papilloma virus and application thereof |
| 09/23/2009 | CN101538318A Signal peptide, coding genes thereof and application |
| 09/23/2009 | CN101538317A Polypeptide hydrous salt of direct thrombin inhibitor and synthesis method thereof |
| 09/23/2009 | CN101538316A Method for preparing Eptifibatide with solid phase method |
| 09/23/2009 | CN101538315A Method for preparing Leuprorelin by combination of solid phase method and liquid phase method |
| 09/23/2009 | CN101538314A Method for purifying Eptifibatide |
| 09/23/2009 | CN101538313A Peptide-based compounds |
| 09/23/2009 | CN101537190A Peptide-based compounds |
| 09/23/2009 | CN100543034C Integrase inhibiting peptide and its application in preparing AIDS-treating medicine |
| 09/23/2009 | CN100543033C Half electric charge matching nonapeptide and application thereof |
| 09/22/2009 | US7592432 selectively splitting the polypeptide at a Cys-His site, by hydrolysis in presence of a palladium promotor dissolved in formic acid; purification with by-product inhibition |
| 09/22/2009 | US7592424 Ion channel-like polypeptide and use thereof |
| 09/22/2009 | US7592421 antigens, immunogens for therapy of Non-Hodgkins Lymphoma diseases; using the peptides to elicit an immune response against human leukocyte antigen class II antigen; autoimmune diseases; biodrugs |
| 09/22/2009 | US7592316 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 09/22/2009 | US7592309 Method of using a peptide having analgesic and antitumor activity from scorpion |
| 09/22/2009 | US7592304 Metal-binding compounds and uses therefor |
| 09/22/2009 | US7592167 Functional peptide fiber, production thereof and method for recovering peptide chains |
| 09/22/2009 | US7592007 Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies |
| 09/22/2009 | US7591995 Cobalamin conjugates useful as imaging and therapeutic agents |
| 09/17/2009 | WO2009113880A1 Biomarkers |
| 09/17/2009 | WO2009113879A1 Biomarkers |
| 09/17/2009 | WO2009113661A1 Cyclic compound and salt thereof |
| 09/17/2009 | WO2009113603A1 Transcriptional repressor peptides and genes for the same |
| 09/17/2009 | WO2009113480A1 Therapeutic agent for cerebral infarction |
| 09/17/2009 | WO2009112075A1 Peptides and aptamers thereof as specific modulators of mutant p53 function |
| 09/17/2009 | WO2002072597A9 Helicomimetics and stabilized lxxll peptidomimetics |
| 09/17/2009 | US20090235393 Seedy 1 nucleic acids for making plants having changed growth characteristics |